Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes

Diabetes Res Clin Pract. 2010 Sep;89(3):e49-52. doi: 10.1016/j.diabres.2010.06.004.

Abstract

We evaluated incretin secretion and dipeptidyl peptidase (DPP)-IV activity in Korean type 2 diabetic patients compared with non-diabetic subjects. Type 2 diabetic patients showed intact GLP-1 and total GIP levels similar to those in non-diabetic subjects. Serum DPP-IV activity was significantly higher in type 2 diabetic patients (p=0.022).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian People
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / metabolism*
  • Dipeptidyl Peptidase 4 / blood*
  • Female
  • Glucagon-Like Peptide 1 / blood
  • Humans
  • Incretins / metabolism*
  • Male
  • Middle Aged

Substances

  • Incretins
  • Glucagon-Like Peptide 1
  • Dipeptidyl Peptidase 4